Correlated Drug Terms (2)

---

	Name (Synonyms)	Correlation
drug343	Bevacizumab Injection Wiki	0.71
drug2300	Standard Care Wiki	0.50

Correlated MeSH Terms (3)

---

	Name (Synonyms)	Correlation
D011014	Pneumonia NIH	0.06
D045169	Severe Acute Respiratory Syndrome NIH	0.05
D018352	Coronavirus Infections NIH	0.04

Correlated HPO Terms (1)

---

	Name (Synonyms)	Correlation
HP:0002090	Pneumonia HPO	0.06

Primary Outcomes

Description: Hospitalization associated with desaturation (SpO2 ≤92%) or death due to any cause

Measure: Hospitalization or death

Time: 15 days following randomization

---

Secondary Outcomes

Description: Death due to any cause

Measure: All-cause mortality

Time: 15 days following randomization

---

Description: Death due to any cause

Measure: All-cause mortality

Time: 28 days following randomization

---

Description: Length of time between randomization and hospitalization associated with desaturation (SpO2 ≤92%)

Measure: Time to hospitalization

Time: 28 days following randomization

---

Description: Total duration of hospitalization associated with desaturation (SpO2 ≤92%)

Measure: Length of hospitalization

Time: 28 days following randomization

---

Description: Proportion of participants admitted to an intensive care unit

Measure: Admission to intensive care

Time: 28 days following randomization

---

Description: Proportion of participants having an adverse event

Measure: Adverse events

Time: 28 days following randomization

---

Description: Proportion of participants having a serious adverse event

Measure: Serious adverse events

Time: 28 days following randomization

---